Evidence map›Paper›PMID 36345394›Full record

ReviewData science and engineering2022

Dimensionality Reduction in Surrogate Modeling: A Review of Combined Methods.

Chun Kit Jeffery Hou, Kamran Behdinan

Abstract readReview
In one paragraph

Review in Data science and engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. CuPCA: a web server for pan-cancer association analysis of large-scale cuproptosis-related genes.Database : the journal of biological databases and curation · 2024
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chun Kit Jeffery HouDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON Canada.ORCID 0000-0003-3286-3129
Kamran BehdinanDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON Canada.ORCID 0000-0002-1873-9837

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surrogate modeling has been popularized as an alternative to full-scale models in complex engineering processes such as manufacturing and computer-assisted engineering. The modeling demand exponentially increases with complexity and number of system parameters, which consequently requires higher-dimensional engineering solving techniques. This is known as the curse of dimensionality. Surrogate models are commonly used to replace costly computational simulations and modeling of complex geometries. However, an ongoing challenge is to reduce execution and memory consumption of high-complexity processes, which often exhibit nonlinear phenomena. Dimensionality reduction algorithms have been employed for feature extraction, selection, and elimination for simplifying surrogate models of high-dimensional problems. By applying dimensionality reduction to surrogate models, less computation is required to generate surrogate model parts while retaining sufficient representation accuracy of the full process. This paper aims to review the current literature on dimensionality reduction integrated with surrogate modeling methods. A review of the current state-of-the-art dimensionality reduction and surrogate modeling methods is introduced with a discussion of their mathematical implications, applications, and limitations. Finally, current studies that combine the two topics are discussed and avenues of further research are presented.

Indexed as

Dimensionality reductionHigh dimensionalityMachine learningNeural networksSurrogate modeling

Identifiers

PMID36345394
PMCPMC9633505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.